These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 30985337)
1. Hypoxia, hypoxia-inducible transcription factors and oxygen-sensing prolyl hydroxylases in bone development and homeostasis. Stegen S; Carmeliet G Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):328-335. PubMed ID: 30985337 [TBL] [Abstract][Full Text] [Related]
2. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. Wu C; Rankin EB; Castellini L; Alcudia JF; LaGory EL; Andersen R; Rhodes SD; Wilson TL; Mohammad KS; Castillo AB; Guise TA; Schipani E; Giaccia AJ Genes Dev; 2015 Apr; 29(8):817-31. PubMed ID: 25846796 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factors link iron homeostasis and erythropoiesis. Shah YM; Xie L Gastroenterology; 2014 Mar; 146(3):630-42. PubMed ID: 24389303 [TBL] [Abstract][Full Text] [Related]
4. Vascular biology and bone formation: hints from HIF. Towler DA J Clin Invest; 2007 Jun; 117(6):1477-80. PubMed ID: 17549250 [TBL] [Abstract][Full Text] [Related]
5. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. Wang Y; Wan C; Deng L; Liu X; Cao X; Gilbert SR; Bouxsein ML; Faugere MC; Guldberg RE; Gerstenfeld LC; Haase VH; Johnson RS; Schipani E; Clemens TL J Clin Invest; 2007 Jun; 117(6):1616-26. PubMed ID: 17549257 [TBL] [Abstract][Full Text] [Related]
6. The hypoxia-inducible factor pathway, prolyl hydroxylase domain protein inhibitors, and their roles in bone repair and regeneration. Fan L; Li J; Yu Z; Dang X; Wang K Biomed Res Int; 2014; 2014():239356. PubMed ID: 24895555 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia Signaling in the Skeleton: Implications for Bone Health. Yellowley CE; Genetos DC Curr Osteoporos Rep; 2019 Feb; 17(1):26-35. PubMed ID: 30725321 [TBL] [Abstract][Full Text] [Related]
9. Acidosis Acts through HSP90 in a PHD/VHL-Independent Manner to Promote HIF Function and Stem Cell Maintenance in Glioma. Filatova A; Seidel S; Böğürcü N; Gräf S; Garvalov BK; Acker T Cancer Res; 2016 Oct; 76(19):5845-5856. PubMed ID: 27488520 [TBL] [Abstract][Full Text] [Related]
10. HIF targets in bone remodeling and metastatic disease. Johnson RW; Schipani E; Giaccia AJ Pharmacol Ther; 2015 Jun; 150():169-77. PubMed ID: 25681658 [TBL] [Abstract][Full Text] [Related]
11. Erythropoietin gene regulation depends on heme-dependent oxygen sensing and assembly of interacting transcription factors. Huang LE; Ho V; Arany Z; Krainc D; Galson D; Tendler D; Livingston DM; Bunn HF Kidney Int; 1997 Feb; 51(2):548-52. PubMed ID: 9027736 [TBL] [Abstract][Full Text] [Related]
12. Andrographolide inhibits hypoxia-induced HIF-1α-driven endothelin 1 secretion by activating Nrf2/HO-1 and promoting the expression of prolyl hydroxylases 2/3 in human endothelial cells. Lin HC; Su SL; Lu CY; Lin AH; Lin WC; Liu CS; Yang YC; Wang HM; Lii CK; Chen HW Environ Toxicol; 2017 Mar; 32(3):918-930. PubMed ID: 27297870 [TBL] [Abstract][Full Text] [Related]
13. Hypoxia Pathway Proteins are Master Regulators of Erythropoiesis. Watts D; Gaete D; Rodriguez D; Hoogewijs D; Rauner M; Sormendi S; Wielockx B Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33143240 [TBL] [Abstract][Full Text] [Related]
14. JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-α protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor. Fukui K; Shinozaki Y; Kobayashi H; Deai K; Yoshiuchi H; Matsui T; Matsuo A; Matsushita M; Tanaka T; Nangaku M Eur J Pharmacol; 2019 Sep; 859():172532. PubMed ID: 31301309 [TBL] [Abstract][Full Text] [Related]
15. Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes. Tojo Y; Sekine H; Hirano I; Pan X; Souma T; Tsujita T; Kawaguchi S; Takeda N; Takeda K; Fong GH; Dan T; Ichinose M; Miyata T; Yamamoto M; Suzuki N Mol Cell Biol; 2015 Aug; 35(15):2658-72. PubMed ID: 26012551 [TBL] [Abstract][Full Text] [Related]
17. Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. Masuyama R; Stockmans I; Torrekens S; Van Looveren R; Maes C; Carmeliet P; Bouillon R; Carmeliet G J Clin Invest; 2006 Dec; 116(12):3150-9. PubMed ID: 17099775 [TBL] [Abstract][Full Text] [Related]
18. Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells. Rauner M; Franke K; Murray M; Singh RP; Hiram-Bab S; Platzbecker U; Gassmann M; Socolovsky M; Neumann D; Gabet Y; Chavakis T; Hofbauer LC; Wielockx B J Bone Miner Res; 2016 Oct; 31(10):1877-1887. PubMed ID: 27082941 [TBL] [Abstract][Full Text] [Related]